SureTrader
Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

PMCB RSS Feed
Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: mick, Hunchbackgeek, $Pistol Pete$, thenewmixer, fraum, concordia
Search This Board: 
Last Post: 4/22/2018 4:12:37 PM - Followers: 787 - Board type: Free - Posts Today: 6

Welcome to PharmaCyte BioTech
An OTCQB Company

http://pharmacyte.com/  




 




 
 
 
 




PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.
 

 

FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment



European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000395.jsp&mid=WC0b01ac058001d12b

 Company Address
   
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com
http://pharmacyte.com/
 

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
848,904,665 a/o Aug 29, 2016

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

Float:
817,204,665 a/o Aug 29, 2016


For more updated information please visit: 


http://www.otcmarkets.com/stock/PMCB/profile


Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations


Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States

 

   All News Releases: 

http://www.pharmacytebiotech.com/news/

 


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans.


http://austrianova.com/products/ 



Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President
 

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director


Carlos A. Trujillo – Chief Financial Officer and Director


Walter H. Gunzburg – Chief Scientific Officer


Dr. Matthias Lohr as Chairman of Scientific Advisory Board


Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board

 


 

 

 


***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.





 
 


                                   

 
 
SureTrader
PMCB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
PMCB News: Quarterly Report (10-q) 03/19/2018 04:41:09 PM
PMCB News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 02/22/2018 04:30:00 PM
PMCB News: Current Report Filing (8-k) 02/22/2018 04:26:40 PM
PMCB News: Quarterly Report (10-q) 12/14/2017 04:51:05 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#82662  Sticky Note $PMCB PharmaCyte Biotech Successfully Completes Multiple $Pistol Pete$ 04/17/18 12:02:29 PM
#81636  Sticky Note Jun 6, 2011 Nuvilex, Inc. Readies Pancreatic Cancer concordia 03/09/18 09:34:06 AM
#80476  Sticky Note PMCBs CC https://fccdl.in/1r0d8hpkC. thenewmixer 01/30/18 01:43:58 PM
#80354  Sticky Note $PMCB A Must Watch Video PMCB $Pistol Pete$ 01/24/18 05:30:46 PM
#79557  Sticky Note HUGE READ MY FRIEND/ PHARMACYTE BIOTECH/ $PMCB/ STAY mick 01/10/18 10:06:32 AM
#82708   Each new announcement shows us-how bogus bearspread 04/22/18 04:12:37 PM
#82707   Do you mean this one? purplehp 04/22/18 09:58:26 AM
#82706   Do you have the article about ciab and 1234jklm 04/22/18 06:07:45 AM
#82705   I can’t disagree with anything you said. BioInvestor4 04/22/18 06:05:28 AM
#82704   The future of chemotherapy 1234jklm 04/22/18 05:56:51 AM
#82703   I don’t think so musky. 1234jklm 04/22/18 05:04:23 AM
#82702   We all know that Siligon Pharma is partnering oldmusky 04/21/18 07:38:58 AM
#82701   :) The Promised Land 04/21/18 01:15:51 AM
#82700   Just read this article again. It references Practical caddyshack 04/21/18 12:02:34 AM
#82698   Why would anyone sell at this stage for 1234jklm 04/20/18 02:01:09 PM
#82697   I am still really happy about how the NolaHedge 04/20/18 01:59:16 PM
#82696   The CALM Before #THESTORM The Promised Land 04/20/18 01:43:29 PM
#82695   Enjoy your weekend JJ Go $PMCB $Pistol Pete$ 04/20/18 12:23:25 PM
#82694   Thanks for the insight Pete. And thank you Jimmy Joe 04/20/18 12:21:59 PM
#82693   I wouldn't worry about that. Just have XCypher73 04/20/18 11:55:32 AM
#82692   Back to anemic trading. Less than $5,000 traded rcstock 04/20/18 11:18:17 AM
#82691   Merck announced new lung cancer trial results this week 1234jklm 04/19/18 07:39:09 PM
#82690   How was it a Merck test? ... I PINKribbon 04/19/18 06:00:41 PM
#82689   Yep $Pistol Pete$ 04/19/18 02:02:19 PM
#82688   Agreed. At this point, it doesn't seem XCypher73 04/19/18 01:58:17 PM
#82687   I am here with you and I am $Pistol Pete$ 04/19/18 10:56:55 AM
#82686   As long as things are moving forward, I'm Syzygenic 04/19/18 10:41:49 AM
#82685   Late June or July is awesome but Aug $Pistol Pete$ 04/19/18 10:37:53 AM
#82684   Successful tests bring confidence in the company and technology 1234jklm 04/19/18 09:27:42 AM
#82683   Love the optimism. ambitious1 04/19/18 09:14:17 AM
#82681   Yes I also think late june or early july A2Z 04/19/18 08:59:45 AM
#82680   Agreed. Late June early July 1234jklm 04/19/18 08:54:25 AM
#82679   My opinion is late June/early July. BioInvestor4 04/19/18 08:14:52 AM
#82678   Thanks for the link...can I say 2 names...Yuen efood125 04/19/18 08:14:00 AM
#82677   :) They Have an extraordinary amount of Gold. The Promised Land 04/19/18 07:53:07 AM
#82676   Chinese money and biotech 1234jklm 04/19/18 07:26:14 AM
#82675   I am looking for Aug timeframe for IND $Pistol Pete$ 04/19/18 02:25:51 AM
#82674   Good catch Uboat. Nice to see you catch Jimmy Joe 04/19/18 12:06:38 AM
#82673   The volume is starting to impress again 1234jklm 04/18/18 06:45:03 PM
#82672   I feel it too RC....feel sorry for the efood125 04/18/18 06:30:20 PM
#82671   I sense a "tiny" bit of momentum building. rcstock 04/18/18 02:16:39 PM
#82670   Closer and closer we get! Weeks away BioInvestor4 04/18/18 10:04:18 AM
#82669   Until that IND is submitted, the PPS isn't XCypher73 04/18/18 09:42:59 AM
#82668   $PMCB Fellows (READ HERE: DD)….Welcome to PharmaCyte $Pistol Pete$ 04/17/18 11:10:53 PM
#82667   $PMCB Management Team PMCB $Pistol Pete$ 04/17/18 10:59:10 PM
#82666   $PMCB expect to get our IND application to $Pistol Pete$ 04/17/18 10:45:37 PM
#82665   $PMCB Daily and Weekly Chart http://stockchar $Pistol Pete$ 04/17/18 08:46:53 PM
#82664   Also good to see comments reguarding diabetes as caddyshack 04/17/18 07:23:01 PM
#82662   $PMCB PharmaCyte Biotech Successfully Completes Multiple $Pistol Pete$ 04/17/18 12:02:29 PM
#82661   Uboat if it could work on Prostate cancer longboarder7892 04/17/18 11:37:14 AM
#82660   Careful Pete... They mis-spelled "Hodgkin's" If they have Uboat 04/17/18 11:12:24 AM
#82659   Indeed it is! Glad to hear you XCypher73 04/17/18 11:09:41 AM
#82658   Welcome to PMCB board my Friend. Glad to $Pistol Pete$ 04/17/18 10:59:50 AM
#82657   Good news. :) candylandcure 04/17/18 09:50:40 AM
#82654   Excellent...FDA requirements list for IND filing is getting efood125 04/17/18 09:27:21 AM
PostSubject